AstraZeneca's dynamic duo wants to dominate in cancer drugs - STAT

  1. AstraZeneca's dynamic duo wants to dominate in cancer drugs  STAT
  2. Pancreatic cancer therapy sheds light on the disease's ties to BRCA mutation  CNN
  3. ASCO: AZ, Merck's Lynparza fends off pancreatic cancer, cutting progression risk in half  FiercePharma
  4. New drug therapy slows spread of pancreatic cancer: study  St. Lucia News Online
  5. Lynparza stalls pancreatic cancer in patients with BRCA mutations: study  CNA
  6. View full coverage on Google News


from Top stories - Google News http://bit.ly/2W5VroN

Comments

Popular posts from this blog

U.S.-Canada 4 Nations Face-Off final draws 9.3 million viewers, most-watched NHL-sanctioned game in decades - The New York Times

Georgia hospitals test ‘game-changer’ pancreatic cancer drugs - Atlanta Journal-Constitution

Before Carlos Alcaraz Was Great, He Was Good Enough to Be Lucky - The New York Times